Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioMarin receives FDA approval for Palynziq use in adolescents
Palynziq is the only enzyme substitution therapy approved to reduce blood phenylalanine concentrations in individuals with phenylketonuria. Credit: Jack_the_sparrow / Shutterstock.com.
Palynziq is the only enzyme substitution therapy approved to reduce blood phenylalanine concentrations in individuals with phenylketonuria. Credit: Jack_the_sparrow / Shutterstock.com.